Prescribing combined OCs may not be effective for certain ovarian cysts
A recent review of seven randomized, controlled trials involving 500 women in four countries found that combined oral contraceptives are of no use in treating functional ovarian cysts that either occur spontaneously or develop as a result of ovulation induction.
A recent review of seven randomized, controlled trials involving 500 women in four countries finds that combined oral contraceptives are of no use in treating functional ovarian cysts that either occur spontaneously or develop as a result of ovulation induction.
The review reveals that most ovarian cysts in premenopausal women resolve spontaneously within a few menstrual cycles and that those that don't tend to be pathological (eg, endometrioma or paraovarian), rather than physiological in nature.
Because most of these cysts spontaneously regress, the review authors concluded that nonoperative management is almost always preferred in young women, unless the cyst becomes symptomatic or suggestive of an alternative etiology.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
